Measurement properties of the SF-12 health survey in Parkinson's disease.

The 12-item Short-Form Health Survey (SF-12) is an abbreviated version of the SF-36, one of the most widely used patient-reported health outcome rating scales. Similar to the SF-36, it yields summary scores of physical and mental health (PCS and MCS, respectively). However, SF-36 derived PCS and MCS scores have not been found valid in neurological disorders such as Parkinson's disease (PD). Here we used modern psychometric methodology (Rasch analysis) to test the SF-12 in PD, and explored the appropriateness of a total SF-12 score representing overall health. SF-12 data from 150 non-demented people with PD (56% men; mean age/PD-duration, 70/5 years) were analyzed regarding Rasch model fit for the PCS, MCS, as well as for the full SF-12. Data showed some signs of misfit to the Rasch model for all three scales (overall item-trait interaction, P ≥ 0.003; reliability, ≥ 0.85). For example, all scales exhibited signs of dependency between item responses, and the PCS measured with relatively low precision. Model fit (but not measurement precision) was improved following deletion of one PCS and one MCS item (overall item-trait interaction, P ≥ 0.387; reliability, ≥ 0.82). These observations suggest that the SF-12 can be used as a coarse health survey tool in PD and that a total SF-12 may be useful as a measure of overall health. However, its appropriateness as an outcome measure can be questioned and it is somewhat unclear exactly what the derived scores represent. As such, the SF-12 should probably be considered an assessment tool (or index) rather than a measurement instrument.

[1]  A. Westergren,et al.  Construct validity of the SF-12 in three different samples. , 2012, Journal of evaluation in clinical practice.

[2]  L. Kazis,et al.  Deriving SF-12v2 physical and mental health summary scores: a comparison of different scoring algorithms , 2010, Quality of Life Research.

[3]  Colin R. Martin,et al.  The factor structure of the SF-36 in Parkinson's disease. , 2009, Journal of evaluation in clinical practice.

[4]  J. Hobart,et al.  Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. , 2009, Health technology assessment.

[5]  J. Hobart,et al.  Testing the SF-36 in Parkinson's disease , 2008, Journal of Neurology.

[6]  Ron D Hays,et al.  Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1 , 2007, Health and quality of life outcomes.

[7]  C. Nygren,et al.  The 39 item Parkinson’s disease questionnaire (PDQ-39) revisited: implications for evidence based medicine , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  J. Lou,et al.  Fatigue in Parkinson's disease: A review , 2007, Movement disorders : official journal of the Movement Disorder Society.

[9]  J. Hobart,et al.  Evidence‐based guidelines for using the Short Form 36 in cervical dystonia , 2007, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Hobart,et al.  Measuring Outcomes in Cervical Spine Surgery: Think Twice Before Using the SF-36 , 2006, Spine.

[11]  G. Lankhorst,et al.  Dimensional structure of the SF-36 in neurological patients. , 2006, Journal of clinical epidemiology.

[12]  Alan Tennant,et al.  Application of Rasch analysis in the development and application of quality of life instruments. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  D. Andrich,et al.  Is the sense of coherence-instrument applicable on adolescents? A latent trait analysis using Rasch-modelling , 2004 .

[14]  D. Cella,et al.  Issues in the development of an item bank. , 2003, Archives of physical medicine and rehabilitation.

[15]  David J. Hand,et al.  Causal variables, indicator variables and measurement scales: an example from quality of life , 2002 .

[16]  J. Hobart,et al.  Quality of Life Measurement After Stroke: Uses and Abuses of the SF-36 , 2002, Stroke.

[17]  M. Swash,et al.  Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions , 2002, Journal of Neurology.

[18]  A. Thompson,et al.  The SF-36 in multiple sclerosis: why basic assumptions must be tested , 2001, Journal of Neurology Neurosurgery & Psychiatry.

[19]  T Riise,et al.  Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population , 2000, Medical care.

[20]  G. Sawle Movement Disorders in Clinical Practice , 1999 .

[21]  Jeffrey A. Johnson,et al.  Replicability of SF-36 summary scores by the SF-12 in stroke patients. , 1999, Stroke.

[22]  J. Ware,et al.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[23]  Crispin Jenkinson,et al.  Development and Testing of the UK SF-12 , 1997 .

[24]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[25]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[26]  John E. Ware,et al.  The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection , 1992, Medical care.

[27]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[28]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[29]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[30]  I. Marais Response dependence and the measurement of change. , 2009, Journal of applied measurement.

[31]  D. Andrich,et al.  Effects of varying magnitude and patterns of response dependence in the unidimensional Rasch model. , 2008, Journal of applied measurement.

[32]  David H. Wilson,et al.  Rethinking and rescoring the SF-12 , 2005, Sozial- und Präventivmedizin.

[33]  C. Hagquist Evaluating composite health measures using Rasch modelling: An illustrative example , 2005, Sozial- und Präventivmedizin.

[34]  J. Ware SF-36 health survey: Manual and interpretation guide , 2003 .

[35]  Everett V. Smith Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. , 2002, Journal of applied measurement.

[36]  Everett V. Smith,et al.  Evidence for the reliability of measures and validity of measure interpretation: a Rasch measurement perspective. , 2001, Journal of applied measurement.

[37]  B. Wright,et al.  Mapping variables. , 1999, Journal of outcome measurement.

[38]  C. Jenkinson,et al.  Development and testing of the UK SF-12 (short form health survey). , 1997, Journal of health services research & policy.

[39]  Richard M. Smith A comparison of methods for determining dimensionality in Rasch measurement , 1996 .

[40]  R. Lennox,et al.  Conventional wisdom on measurement: A structural equation perspective. , 1991 .

[41]  David Andrich,et al.  Rasch Models For Measurement , 1988 .

[42]  G. Masters,et al.  Rating scale analysis , 1982 .